European Commission approves Sanofi's Cenrifki

The European Commission has approved the market launch of Cenrifki, a new drug developed by French pharmaceutical group Sanofi.

Published 20sem1 sourceNotableupdated 14sem
Lire en français
≈ 20s

The fact

This approval came after assessment of the treatment's clinical and safety file.

The green light paves the way for commercialization of the product across the European Union.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Union européenne · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on June 23, 2026
← Back to home
Discover

Read more

All marches →